Endo International (LTS:0Y5F) Change In Receivables : $107 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Endo International Change In Receivables?

Endo International's change in receivables for the quarter that ended in Dec. 2023 was $5 Mil. It means Endo International's Accounts Receivable declined by $5 Mil from Sep. 2023 to Dec. 2023 .

Endo International's change in receivables for the fiscal year that ended in Dec. 2023 was $107 Mil. It means Endo International's Accounts Receivable declined by $107 Mil from Dec. 2022 to Dec. 2023 .

Endo International's Accounts Receivable for the quarter that ended in Dec. 2023 was $387 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Endo International's Days Sales Outstanding for the three months ended in Dec. 2023 was 70.93.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Endo International's liquidation value for the three months ended in Dec. 2023 was $-10,544 Mil.

Endo International Change In Receivables Historical Data

The historical data trend for Endo International's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Change In Receivables Chart

Endo International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

19.16

-45.79

-82.05

105.91

106.51

Endo International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-48.73	37.69	6.23	57.57	5.02

Endo International Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $107 Mil.

Endo International (LTS:0Y5F) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Endo International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	386.919	/	497.734	*	91
=	70.93

2. In Ben Graham's calculation of liquidation value, Endo International's accounts receivable are only considered to be worth 75% of book value:

Endo International's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	777.919	-	11734.854	+	0.75 * 386.919	+	0.5 * 246.017
=	-10,544

Endo International Change In Receivables Related Terms

Thank you for viewing the detailed overview of Endo International's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo International (LTS:0Y5F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4

Website

https://www.endo.com

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (LTS:0Y5F) Headlines

No Headlines